ceFAZolin 3 G in 0 — Class II drug recall D-0897-2021
Terminated recall by IntegraDose Compounding Services LLC, reported 2021-10-06, distributed in MA, MN, NH. Lack of sterility assurance.
| Recall number | D-0897-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | IntegraDose Compounding Services LLC, Minneapolis, MN, United States |
| Recall initiated | 2021-09-17 |
| Classified | 2021-09-30 |
| Reported by FDA | 2021-10-06 |
| Terminated | 2022-10-02 |
| Distributed | MA, MN, NH |
| Quantity | 589 bags |
| Reason classes | sterility |
| NDC | 71139-7153-01 |
| Lot numbers | 20210722CEF-2, 20210728CEF-1 |
| Expiration dates | 2021-09-20, 2021-09-26 |
Product
ceFAZolin 3 G in 0.9% Sodium Chloride, 115 mL Bag for Injection, Sterile Product, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC: 71139-7153-1
Reason for recall
Lack of sterility assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0897-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.